About: Mesenchymal stem cells in the fight against viruses: face to face with the invisible enemy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mesenchymal stem cells in the fight against viruses: face to face with the invisible enemy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Mesenchymal stem cells in the fight against viruses: face to face with the invisible enemy
Creator	Saleh, Fatima Sleem, Aleen
Source	Elsevier; Medline; PMC
abstract	The relative ease of isolation of mesenchymal stem cells (MSCs) from different tissues coupled with their culture expansion in vitro and their differentiation capacity to mesodermal, endodermal and ectodermal lineages have made these cells attractive for a large number of therapeutic applications. In recent years, there has been remarkable progress in the utilization of MSCs in diverse clinical indications both in animal models and human clinical trials. However, the potential of MSCs to control or treat viral diseases is still in its infancy. In this study, we report quantitative data on the MSC-based clinical trials over the last ten years as they appear on the online database of clinical research studies from US National Institutes of Health. In particular, we provide comprehensive review of either completed or ongoing clinical trials using MSCs for virus-associated diseases focusing on HIV, hepatitis B virus and COVID-19 virus.
has issue date	2020-05-01(xsd:dateTime)
bibo:doi	10.1016/j.retram.2020.04.003
bibo:pmid	32616467
has license	no-cc
sha1sum (hex)	ee2d044a752fd2b4410e679ebf35752c4752607d
schema:url	https://doi.org/10.1016/j.retram.2020.04.003
resource representing a document's title	Mesenchymal stem cells in the fight against viruses: face to face with the invisible enemy
has PubMed Central identifier	PMC7252154
has PubMed identifier	32616467
schema:publication	Curr Res Transl Med
resource representing a document's body	covid:ee2d044a752fd2b4410e679ebf35752c4752607d#body_text
is schema:about of	named entity 'provide' named entity 'Mesenchymal stem cells' named entity 'ONLINE' named entity 'DATA' named entity 'study' named entity 'MSCs' named entity 'viral diseases' named entity 'diseases' named entity 'clinical trials' named entity 'potential' named entity 'endodermal' named entity 'face' named entity 'therapeutic applications' named entity 'MSCs' named entity 'US National Institutes of Health' named entity 'endodermal' named entity 'clinical research' named entity 'MSCs' named entity 'quantitative data' named entity 'Mesenchymal stem cells' named entity 'viruses' named entity 'National' named entity 'CD105' named entity 'stem cells' named entity 'HBV' named entity 'immunodeficiency' named entity 'HBV' named entity 'stromal cells' named entity 'cell-based therapy' named entity 'MSCs' named entity 'Mesenchymal' named entity 'CD73' named entity 'remission' named entity 'Berlin patient' named entity 'MSCs' named entity 'viral load' named entity 'stem cells' named entity 'microvasculature' named entity 'HIV' named entity 'lung' named entity 'MSCs' named entity 'clinical trials' named entity 'HBV' named entity 'MSCs' named entity 'MSCs' named entity 'intravenous infusion' named entity 'HIV' named entity 'immunogenicity' named entity 'cell lines' named entity 'morbidity' named entity 'MSCs' named entity 'hematopoietic stem cells' named entity 'pro-inflammatory cytokine' named entity 'HIV' named entity 'Highly active antiretroviral therapy' named entity 'follow-up' named entity 'opportunistic infections' named entity 'CD45' named entity 'HIV' named entity 'MSCs' named entity 'exosomes' named entity 'virus' named entity 'clinical outcomes' named entity 'hepatitis' named entity 'HIV infections' named entity 'MSCs' named entity 'long-term' named entity 'ethical concerns' named entity 'COVID-19' named entity 'HBV' named entity 'HIV-infected patients' named entity 'CCR5' named entity 'transfusion' named entity 'liver failure' named entity 'cirrhosis' named entity 'anti-inflammatory' named entity 'microenvironments' named entity 'therapeutic strategies' named entity 'TNF-α' named entity 'CD90'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software